SEC Comment Letter for GSK (GSK) — Nov 30, 2011
GSK plc
Date: Nov. 30, 2011 · CIK: 0001131399 · Accession: 0000000000-11-068914
AI Filing Summary & Sentiment
File numbers found in text: 001-15170
Show Raw Text
November 30, 2011 Via E-mail Mr. Simon Dingemans Chief Financial Officer GlaxoSmithKline plc 980 Great West Road Brentford, TW8 9GS England Re: GlaxoSmithKline plc Form 20-F for Fiscal Year Ended December 31, 2010 Filed March 4, 2011 File No. 001-15170 Dear Mr. Dingemans: We have completed our review of your filing. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Joel Parker Joel Parker Accounting Branch Chief